CARLA GROSSMAN: Open Payments
NPI 1811778723 · SUFFERN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 10 payments from 7 companies in 2025. Trend: 2023 $105 · 2024 $30 · 2025 $505
Food & beverage: $368Education: $137
| Company | Payments | Amount |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $287 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Incyte Corporation | 1 | $29 |
| Caris MPI, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
Products named: DERMABOND, KEYTRUDA, TAGRISSO, ENHERTU, MONJUVI, MI CANCER SEEK, KISQALI, VERZENIO.
Industry payments across NY — which companies pay providers there.
